Mindray
{{Short description|Chinese medical instrumentation manufacturer}}
{{Infobox company
| name = Mindray
| logo = Mindray logo (2024).png
| image = Mindray_headquarter.jpg
| image_caption = Headquarters in Shenzhen
| type = Public
| traded_as = {{SZSE|300760}}
CSI A50
| foundation = {{start date and age|1991||}}
Shenzhen
| location = Shenzhen, Guangdong, China
| key_people = Li Xiting (President and co-CEO)
Xu Hang (co-CEO)
Cheng Minghe (Executive VP)
| industry = Medical Devices
| products = Patient Monitors, ECG, Pulse Oxymeters, Telemetery, Ultrasound Systems, Anesthesia Delivery Systems, Hematology Analyzers, Chemistry Analyzers, Regents, Veterinary Equipment
| revenue = {{profit}} $4.3 billion USD (2022)
| operating_income =
| net_income = {{profit}} $1.359 Billion USD (2022)
| num_employees = 7,500 (2019){{cite web|url=https://www.mindraynorthamerica.com/about/|title=About|publisher=Mindray}}
| parent =
| divisions =
| subsid =
| homepage = {{URL|http://www.mindray.com/}}
| footnotes =
}}
Mindray Medical International Limited ({{zh|s=迈瑞医疗国际有限公司|t=邁瑞醫療國際有限公司|p=Màiruì Yīliáo Guójì Yǒuxiàn Gōngsī}}) is a Chinese multinational medical instrumentation manufacturer based in Shenzhen, Guangdong. Mindray designs and produces medical equipment and accessories for both human and veterinary use. The company is organized into three key business lines: Patient Monitoring & Life Support, In-Vitro Diagnostic Products, and Medical Imaging Systems. In 2008, Mindray was recognized as China's largest medical device manufacturer.{{cite web|url=http://bg2.mofcom.gov.cn/aarticle/supplydemandofchina/cooperation/200509/20050900369369.html|title=China's Largest Medical Device Manufacturer|access-date=2008-02-04}}
History
Mindray was founded in 1991 in Shenzhen, Guangdong by seven former employees of Anke ({{lang|zh|安科}}), including Li Xiting ({{lang|zh|李西廷}}), Xu Hang ({{lang|zh|徐航}}) and Cheng Minghe ({{lang|zh|成明和}}).{{Cite web|url=http://cj.sina.com.cn/article/detail/6066470577/188555|title=中国合伙人：迈瑞三剑客创业史|date=2017-03-15|website=Sina|access-date=2019-05-10}} It grew by providing domestic patient monitoring, imaging, and other diagnostic products. Mindray maintains 41 subsidiaries and branch offices in 31 countries, as well as 32 branch offices in China. Mindray was listed on the NYSE in September 2006 and delisted in March 2016 to apply for a re-listing in China's A-Share market.{{citation needed|date=September 2021}} Mindray was re-listed in the Shenzhen Stock Exchange in October 2018.{{citation needed|date=September 2021}}
Mindray faced hiring controversy at the end of 2018 when it rescinded job offers from 254 university students due to changing economic conditions.{{cite web|url=https://www.scmp.com/economy/china-economy/article/2180796/how-chinas-worsening-economic-woes-are-shattering-dreams-its|title=How China's economic woes are smashing its top graduates' dreams|date=7 January 2019|website=South China Morning Post}} The company reinstated the offers in early 2019 citing 'corporate social responsibility' after public outcry.{{cite web|url=https://www.scmp.com/economy/china-economy/article/2181400/youre-rehired-chinese-firm-overturns-decision-cancel|title=You're rehired! Chinese firm restores job offers to over 200 graduates|date=9 January 2019|website=South China Morning Post}}
Mindray partnered with Korle Bu Teaching Hospital in January 2019 to improve diagnostic patient care in Ghana. The company donated a SAL 6000 analyzer to improve local lab test efficiency.{{cite web|url=https://www.businessghana.com/site/news/general/180798/Korle-Bu-Hospital-inaugurates-state-of-the-art-analyzer-laboratory|title=Korle-Bu Hospital inaugurates state-of-the-art analyzer laboratory|website=BusinessGhana}}
Divisions
The Patient Monitoring & Life Support division develops and manufactures multi-parameter patient monitors, biotelemetry systems, anesthesia delivery systems, defibrillators, ECG machines, pulse oxymeters, hospital beds, mounting systems and IT solutions.{{cite press release
| title = Frost & Sullivan Commends Mindray Medical International for its Global Excellence in Patient Monitoring
| publisher = Frost & Sullivan
| date = 2007-07-30
| url = http://www.frost.com/prod/servlet/press-release.pag?docid=102829330
| access-date = 2009-01-19 }}
In 2008, Mindray purchased the Patient Monitoring division of Datascope Corporation for $209 million to expand their presence outside of China.
The In-Vitro Diagnostic division provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment. This segment offers a range of semi-automated and fully automated diagnostic laboratory instruments for laboratories, clinics, and hospitals. Its products include hematology analyzers, biochemistry analyzers, reagents, a microplate reader and a microplate washer.
Notes
{{reflist}}
{{Hang Seng China 50 Index}}
{{SZSE 100 Index}}
{{FTSE China A50 Index}}
Category:Chinese companies established in 1991
Category:Technology companies established in 1991
Category:Companies formerly listed on the New York Stock Exchange
Category:Companies listed on the Shenzhen Stock Exchange
Category:Medical device manufacturers
Category:Medical technology companies of China
Category:Manufacturing companies based in Shenzhen
Category:2006 initial public offerings
Category:2018 initial public offerings